J. Molner AS operates as a global pharmaceutical company. It focuses on sterile injectable and dermatological drugs for both the United States and Canada. The company was founded by Jason Michael Atticus Grenfell-Gardner in 2015 and is headquartered in Tallinn, Estonia.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company